According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful… [ Get More Details ]
From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical… [ Get More Details ]
Cancer mortality declined more than 2% in 2003, a continuation of the decline that began in 1990.
[ Get More Details ]